Brookstone Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,547
| Closed | -$376K | – | 866 |
|
|
2022
Q3 | $376K | Buy |
1,547
+15
| +1% | +$3.65K | 0.01% | 611 |
|
|
2022
Q2 | $409K | Sell |
1,532
-92
| -6% | -$24.6K | 0.01% | 586 |
|
|
2022
Q1 | $487K | Sell |
1,624
-23
| -1% | -$6.9K | 0.01% | 568 |
|
|
2021
Q4 | $526K | Sell |
1,647
-45
| -3% | -$14.4K | 0.01% | 509 |
|
|
2021
Q3 | $569K | Buy |
1,692
+2
| +0.1% | +$673 | 0.01% | 476 |
|
|
2021
Q2 | $539K | Sell |
1,690
-459
| -21% | -$146K | 0.01% | 466 |
|
|
2021
Q1 | $685K | Sell |
2,149
-72
| -3% | -$23K | 0.03% | 303 |
|
|
2020
Q4 | $720K | Sell |
2,221
-14,318
| -87% | -$4.64M | 0.03% | 281 |
|
|
2020
Q3 | $4.58M | Buy |
16,539
+13,118
| +383% | +$3.63M | 0.21% | 71 |
|
|
2020
Q2 | $826K | Buy |
3,421
+779
| +29% | +$188K | 0.05% | 182 |
|
|
2020
Q1 | $384K | Buy |
2,642
+131
| +5% | +$19K | 0.02% | 236 |
|
|
2019
Q4 | $428K | Buy |
2,511
+92
| +4% | +$15.7K | 0.02% | 295 |
|
|
2019
Q3 | $430K | Buy |
2,419
+695
| +40% | +$124K | 0.02% | 289 |
|
|
2019
Q2 | $449K | Buy |
1,724
+684
| +66% | +$178K | 0.03% | 297 |
|
|
2019
Q1 | $297K | Buy |
1,040
+213
| +26% | +$60.8K | 0.02% | 331 |
|
|
2018
Q4 | $269K | Buy |
827
+70
| +9% | +$22.8K | 0.02% | 239 |
|
|
2018
Q3 | $340K | Sell |
757
-667
| -47% | -$300K | 0.03% | 316 |
|
|
2018
Q2 | $582K | Buy |
1,424
+31
| +2% | +$12.7K | 0.05% | 182 |
|
|
2018
Q1 | $405K | Buy |
+1,393
| New | +$405K | 0.04% | 226 |
|